Appointment
Biotage gets new CEO
Tomas Blomquist, most recently Abbott's Vice President EMEA Cardimetabolic, will join Biotage on November 6, 2019 and will be responsible for the Biotage Group and its 400 employees. he has a long history in the life sciences industry and has sales and management experience with Alere, Analyticon, Johnson & Johnson and Roche.